We investigated the effect of Slit3 repression on chemoresistance of HCC cells by evaluating the growth and survival of LM3 and PLC shSlit3 cells, upon treatment of chemotherapeutic drugs including sorafenib, oxaliplatin and 5-FU for 72 h. This evidence concerns the gene HSPG2 and hepatocellular carcinoma.